InvestorsHub Logo
Followers 208
Posts 18604
Boards Moderated 0
Alias Born 11/10/2012

Re: TheHungryHippo post# 19464

Wednesday, 02/22/2017 7:59:11 AM

Wednesday, February 22, 2017 7:59:11 AM

Post# of 106839
HH, amazing due diligence and comparison of other stem cell biotech companies. Coming across one of your comparisons, I noticed recently as of late last year Ocata Therapeutics (OCAT) was Acquired by Astellas for $379M, so it is surprising or almost unbelievable that USRM is currently valued at the market cap of $250k? I'd like to explore this more with you. In the meantime, do you know what clinical Phase Ocata was at?

http://www.genengnews.com/gen-news-highlights/astellas-to-acquire-ocata-therapeutics-for-379m/81251957

The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.